Ser984

Site Information
GPstPsAsPLPVVTD SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 23112702

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 )
Disease tissue studied:	leukemia ( 2 , 3 ) , acute lymphocytic leukemia ( 1 ) , acute myelogenous leukemia ( 2 , 3 )
Relevant cell line - cell type - tissue:	bone marrow ( 1 , 2 , 3 )

References
1	Gu TL, et al. (2011) Survey of activated FLT3 signaling in leukemia. PLoS One 6, e19169 21552520 Curated Info
2	Gu T (2009) CST Curation Set: 7661; Year: 2009; Biosample/Treatment: tissue, bone marrow/untreated; Disease: acute myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: PXpTPAntibodies Used to Purify Peptides prior to LCMS: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983 Curated Info
3	Gu T (2009) CST Curation Set: 7662; Year: 2009; Biosample/Treatment: tissue, bone marrow/untreated; Disease: acute myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: PXpTPAntibodies Used to Purify Peptides prior to LCMS: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983 Curated Info